NASDAQ
Biodesix, Inc. (BDSX) has a free cash flow growth of -1739.43% as of Friday, May 29, 2026. This represents a 33304.90% decrease compared to its 12-month average of 5.24%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.